Addition of Spironolactone to Dual Blockade of Renin Angiotensin System Dramatically Reduces Severe Proteinuria in Renal Transplant Patients: An Uncontrolled Pilot Study at 6 Months
Authors:
- A. AndrésAAA. Andrés
- N. PolancoNPN. Polanco
- M.J. ToribioMTM.J. Toribio
- R. SantanaRSR. Santana
- E. Gutiérrez MartínezEME. Gutiérrez Martínez
- J. GonzálezJGJ. González
- E. RamírezERE. Ramírez
- A. HernándezAHA. Hernández
- E. MoralesEME. Morales
- M. PragaMPM. Praga
- J.M. MoralesJMJ.M. Morales
- 1 October 2010
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 42 (8) , 2899-2901
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Renin Angiotensin System Blockade in Kidney Transplantation: A Systematic Review of the EvidenceAmerican Journal of Transplantation, 2007
- Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney diseaseKidney International, 2006
- Double-Blind, Placebo-Controlled Study on the Effect of the Aldosterone Receptor Antagonist Spironolactone in Patients Who Have Persistent Proteinuria and Are on Long-Term Angiotensin-Converting Enzyme Inhibitor Therapy, with or without an Angiotensin II Receptor BlockerClinical Journal of the American Society of Nephrology, 2006
- Proteinuria: a new marker of long-term graft and patient survival in kidney transplantationNephrology Dialysis Transplantation, 2004
- PROTEINURIA AFTER RENAL TRANSPLANTATION AFFECTS NOT ONLY GRAFT SURVIVAL BUT ALSO PATIENT SURVIVALTransplantation, 2001